1. Quick Facts
Category: Nootropic / Cognitive Peptide
Risk Level: Moderate
Research Status: Limited Human Research
Administration: Intranasal or Subcutaneous
Typical Frequency: 1–2 Times Daily
Estimated Half-Life: Short Plasma Half-Life / Longer Neurological Effects
Primary Research Interest: Focus / Cognition / Neuroprotection
This material is provided strictly for educational and informational purposes related to peptide research and experimental nootropic compounds. Semax is a biologically active peptide capable of influencing neurological signaling pathways including neurotrophic activity, neurotransmitter regulation, stress adaptation, and cognitive function. Information presented here should not be interpreted as medical advice, treatment recommendations, or encouragement of unsupervised use.
2. Summary
Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH). It has been investigated for potential cognitive, neuroprotective, neuroplasticity, and stress-resilience effects and is commonly discussed within nootropic and neurological research communities.
Research interest in Semax primarily centers around memory, attention, mental performance, neuroprotection, stroke recovery, neurotrophic signaling, and stress adaptation.
What People Commonly Claim
- Improved focus and concentration
- Enhanced memory and learning
- Better stress resilience
- Increased mental energy
- Neuroprotective benefits
What the Literature Actually Shows
- Semax is a synthetic peptide derived from an ACTH fragment.
- Research has investigated cognitive performance, neuroprotection, stroke recovery, and neurotrophic signaling.
- Preclinical studies suggest effects on BDNF, neurotrophins, and other neurochemical pathways.
- Some human studies suggest potential neurological benefits, though evidence remains limited compared with conventional therapies.
- Long-term safety and efficacy remain incompletely characterized.
3. Reconstitution Guide
Intranasal Administration
- Vial Size: 10 mg
- Dilutant Type: BAC Water or Sterile Saline
- Initial Vial Reconstitution: Add 3 mL to the peptide vial
- Transfer Instructions: Withdraw the entire vial contents and transfer into a nasal spray bottle
- Final Spray Bottle Dilution: Add an additional 7 mL of dilutant for a total final volume of 10 mL
- Final Concentration: 1.00 mg/mL
- Spray Bottle Type: Metered spray bottle delivering approximately 0.15–0.20 mL per spray
At this concentration:
• 1 spray (0.15 mL) = 0.15 mg (150 mcg)
• 1 spray (0.20 mL) = 0.20 mg (200 mcg)
• 2 sprays total (1 per nostril) ≈ 400 mcg
Subcutaneous Administration
- Vial Size: 10 mg
- Dilutant Type: BAC Water
- Amount of Dilutant Added: 2.5 mL
- Final Concentration: 4.00 mg/mL
At this concentration:
• 400 mcg = 0.100 mL (10.0 units)
• 1000 mcg = 0.250 mL (25.0 units)
*Different vial sizes may limit reconstitution volume. If your product differs from the specifications listed here, please use the Peptide Calculator to calculate custom concentrations and dosing protocols.
4. Route of Administration
Semax is most commonly administered intranasally. The intranasal route is generally favored in research discussions because it may facilitate direct access to neurological tissues while avoiding gastrointestinal degradation.
- Primary Route: Intranasal Administration
- Alternative Route: Subcutaneous Injection
- Preferred Timing: Morning administration, with an optional early-afternoon dose when utilized more than once daily
- Administration Notes: Intranasal administration remains the most extensively discussed route. Subcutaneous administration is considered substantially more experimental.
5. Common Research Protocols
- Product Strength: 1.00 mg/mL (Intranasal) or 4.00 mg/mL (Subcutaneous)
- Typical Delivered Amount: Approximately 400 mcg intranasally in the morning, with an optional second administration early in the day; 400–1000 mcg daily for experimental subcutaneous protocols
- Frequency: 1–2 times daily
- Cycle Length: Commonly discussed as 2 weeks on / 2 weeks off
- Special Notes: Extended continuous use has not been extensively studied. Some researchers prefer periodic breaks to minimize potential neurological adaptation and maintain subjective effectiveness. Intranasal administration may cause burning, dripping, sneezing, or congestion in some users. Some users report anxiety, headaches, irritability, or overstimulation at higher doses, although controlled long-term data remain limited.
6. Mechanism of Action
Semax appears to influence multiple neurological pathways involved in neuroplasticity, stress adaptation, cognition, and neuroprotection.
Research has investigated effects on neurotrophin signaling, including brain-derived neurotrophic factor (BDNF), as well as gene-expression pathways associated with neuronal survival, inflammation, and neurological recovery.
Potential downstream effects discussed in the literature include:
- Neurotrophin and BDNF signaling support
- Modulation of neurotransmitter systems
- Potential enhancement of attention and cognitive performance
- Stress-adaptation signaling
- Neuroprotective activity
- Neuroplasticity-related effects
The compound is commonly investigated for potential cognitive, neuroprotective, and neuroplasticity-related effects.
7. Potential Benefits
- Potential focus enhancement
- Improved mental clarity
- Possible memory support
- Enhanced stress resilience
- Potential fatigue reduction
- Potential neuroprotective support
- Possible support for neuroplasticity-related pathways
8. Potential Risks / Side Effects
Moderate
- Anxiety
- Headaches
- Irritability
- Overstimulation
- Nasal irritation (intranasal administration)
- Sleep disruption if administered too late in the day
- Potential neurological adaptation with prolonged use
- Limited long-term human safety data
9. Half-Life
Semax is generally described as having a relatively short circulating plasma half-life.
However, downstream neurological and neurotrophic signaling effects may persist significantly longer than measurable plasma concentrations, which may help explain why subjective effects can outlast the peptide’s presence in circulation.
10. Storage Information
- Store refrigerated before and after reconstitution
- Protect from direct light exposure
- Avoid repeated freeze-thaw cycles
- Maintain sterile handling practices during preparation
11. Contraindications / Warnings
- Severe anxiety disorders
- Use alongside strong stimulant medications
- Pregnancy or breastfeeding
- Severe psychiatric disorders
- Known hypersensitivity to peptide compounds
12. Further Study
Mechanism of Action Research
Semax and Pro-Gly-Pro Activate the Transcription of Neurotrophins and Their Receptor Genes
Neuroprotection Research
Advanced Reading
Advanced Reading
Semax, a Synthetic Regulatory Peptide, Affects Copper-Induced Amyloid-β Aggregation
Stress Resilience Research
Antistress Action of Melanocortin Derivatives Associated with Regulation of Gene Expression
13. Research References
- PubMed
- PubMed Central (PMC)
- NIH Publications
- Peer-reviewed neurology journals
- Nootropic peptide research literature
- Neuroprotection and neuroplasticity research
- Neurotrophin and BDNF signaling studies
14. Last Reviewed
June 2026